vs

Side-by-side financial comparison of Everus Construction Group, Inc. (ECG) and F5, Inc. (FFIV). Click either name above to swap in a different company.

Everus Construction Group, Inc. is the larger business by last-quarter revenue ($1.0B vs $811.7M, roughly 1.2× F5, Inc.). F5, Inc. runs the higher net margin — 18.2% vs 5.5%, a 12.8% gap on every dollar of revenue. On growth, Everus Construction Group, Inc. posted the faster year-over-year revenue change (33.2% vs 11.0%). Over the past eight quarters, Everus Construction Group, Inc.'s revenue compounded faster (27.1% CAGR vs 8.0%).

F5, Inc. is an American technology company specializing in application security, multi-cloud management, online fraud prevention, application delivery networking (ADN), application availability and performance, and network security, access, and authorization.

ECG vs FFIV — Head-to-Head

Bigger by revenue
ECG
ECG
1.2× larger
ECG
$1.0B
$811.7M
FFIV
Growing faster (revenue YoY)
ECG
ECG
+22.1% gap
ECG
33.2%
11.0%
FFIV
Higher net margin
FFIV
FFIV
12.8% more per $
FFIV
18.2%
5.5%
ECG
Faster 2-yr revenue CAGR
ECG
ECG
Annualised
ECG
27.1%
8.0%
FFIV

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
ECG
ECG
FFIV
FFIV
Revenue
$1.0B
$811.7M
Net Profit
$55.3M
$148.0M
Gross Margin
11.6%
81.4%
Operating Margin
6.8%
22.1%
Net Margin
5.5%
18.2%
Revenue YoY
33.2%
11.0%
Net Profit YoY
60.4%
1.5%
EPS (diluted)
$1.09
$2.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ECG
ECG
FFIV
FFIV
Q1 26
$811.7M
Q4 25
$1.0B
$822.5M
Q3 25
$986.8M
$810.1M
Q2 25
$921.5M
$780.4M
Q1 25
$826.6M
$731.1M
Q4 24
$759.6M
$766.5M
Q3 24
$761.0M
$746.7M
Q2 24
$703.4M
$695.5M
Net Profit
ECG
ECG
FFIV
FFIV
Q1 26
$148.0M
Q4 25
$55.3M
$180.1M
Q3 25
$57.0M
$190.5M
Q2 25
$52.8M
$189.9M
Q1 25
$36.7M
$145.5M
Q4 24
$34.5M
$166.4M
Q3 24
$41.8M
$165.3M
Q2 24
$39.0M
$144.1M
Gross Margin
ECG
ECG
FFIV
FFIV
Q1 26
81.4%
Q4 25
11.6%
81.5%
Q3 25
12.6%
82.2%
Q2 25
13.0%
81.0%
Q1 25
11.2%
80.7%
Q4 24
11.4%
81.7%
Q3 24
11.8%
80.8%
Q2 24
12.6%
80.4%
Operating Margin
ECG
ECG
FFIV
FFIV
Q1 26
22.1%
Q4 25
6.8%
26.0%
Q3 25
7.3%
25.4%
Q2 25
7.9%
25.2%
Q1 25
6.2%
21.7%
Q4 24
6.1%
26.8%
Q3 24
7.1%
25.6%
Q2 24
7.3%
23.4%
Net Margin
ECG
ECG
FFIV
FFIV
Q1 26
18.2%
Q4 25
5.5%
21.9%
Q3 25
5.8%
23.5%
Q2 25
5.7%
24.3%
Q1 25
4.4%
19.9%
Q4 24
4.5%
21.7%
Q3 24
5.5%
22.1%
Q2 24
5.5%
20.7%
EPS (diluted)
ECG
ECG
FFIV
FFIV
Q1 26
$2.58
Q4 25
$1.09
$3.10
Q3 25
$1.11
$3.25
Q2 25
$1.03
$3.25
Q1 25
$0.72
$2.48
Q4 24
$0.68
$2.82
Q3 24
$0.82
$2.79
Q2 24
$0.76
$2.44

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ECG
ECG
FFIV
FFIV
Cash + ST InvestmentsLiquidity on hand
$1.4B
Total DebtLower is stronger
$281.5M
Stockholders' EquityBook value
$629.8M
$3.6B
Total Assets
$1.7B
$6.5B
Debt / EquityLower = less leverage
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ECG
ECG
FFIV
FFIV
Q1 26
$1.4B
Q4 25
$1.2B
Q3 25
$1.3B
Q2 25
$1.4B
Q1 25
$1.3B
Q4 24
$1.2B
Q3 24
$553.0K
$1.1B
Q2 24
$935.6M
Total Debt
ECG
ECG
FFIV
FFIV
Q1 26
Q4 25
$281.5M
Q3 25
$285.1M
Q2 25
$288.6M
Q1 25
$292.1M
Q4 24
$295.6M
Q3 24
Q2 24
Stockholders' Equity
ECG
ECG
FFIV
FFIV
Q1 26
$3.6B
Q4 25
$629.8M
$3.5B
Q3 25
$573.0M
$3.6B
Q2 25
$514.4M
$3.5B
Q1 25
$460.2M
$3.3B
Q4 24
$422.6M
$3.2B
Q3 24
$453.3M
$3.1B
Q2 24
$490.0M
$3.0B
Total Assets
ECG
ECG
FFIV
FFIV
Q1 26
$6.5B
Q4 25
$1.7B
$6.3B
Q3 25
$1.6B
$6.3B
Q2 25
$1.5B
$6.1B
Q1 25
$1.4B
$5.9B
Q4 24
$1.3B
$5.9B
Q3 24
$1.3B
$5.6B
Q2 24
$5.4B
Debt / Equity
ECG
ECG
FFIV
FFIV
Q1 26
Q4 25
0.45×
Q3 25
0.50×
Q2 25
0.56×
Q1 25
0.63×
Q4 24
0.70×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ECG
ECG
FFIV
FFIV
Operating Cash FlowLast quarter
$48.2M
$525.1M
Free Cash FlowOCF − Capex
$23.5M
FCF MarginFCF / Revenue
2.3%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
0.87×
3.55×
TTM Free Cash FlowTrailing 4 quarters
$90.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ECG
ECG
FFIV
FFIV
Q1 26
$525.1M
Q4 25
$48.2M
$159.2M
Q3 25
$76.2M
$208.1M
Q2 25
$25.3M
$282.2M
Q1 25
$7.1M
$256.6M
Q4 24
$202.8M
Q3 24
$78.9M
$246.5M
Q2 24
$159.0M
Free Cash Flow
ECG
ECG
FFIV
FFIV
Q1 26
Q4 25
$23.5M
$149.5M
Q3 25
$65.7M
$191.9M
Q2 25
$12.3M
$273.7M
Q1 25
$-11.4M
$246.1M
Q4 24
$194.7M
Q3 24
$60.9M
$240.4M
Q2 24
$153.1M
FCF Margin
ECG
ECG
FFIV
FFIV
Q1 26
Q4 25
2.3%
18.2%
Q3 25
6.7%
23.7%
Q2 25
1.3%
35.1%
Q1 25
-1.4%
33.7%
Q4 24
25.4%
Q3 24
8.0%
32.2%
Q2 24
22.0%
Capex Intensity
ECG
ECG
FFIV
FFIV
Q1 26
Q4 25
2.4%
1.2%
Q3 25
1.1%
2.0%
Q2 25
1.4%
1.1%
Q1 25
2.2%
1.4%
Q4 24
1.1%
Q3 24
2.4%
0.8%
Q2 24
0.8%
Cash Conversion
ECG
ECG
FFIV
FFIV
Q1 26
3.55×
Q4 25
0.87×
0.88×
Q3 25
1.34×
1.09×
Q2 25
0.48×
1.49×
Q1 25
0.19×
1.76×
Q4 24
1.22×
Q3 24
1.89×
1.49×
Q2 24
1.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ECG
ECG

Commercial$594.5M59%
Utility$203.5M20%
Industrial$82.8M8%
Institutional$66.1M7%
Service And Other$28.4M3%
Transportation$24.2M2%
Renewables$19.8M2%

FFIV
FFIV

Segment breakdown not available.

Related Comparisons